Sanofis Dupixent wins U.S. approval for bigger use –

May 20 (Reuters) – Sanofi (SASY.PA) on Friday won expanded U.S. approval for its best-selling Dupixent injection to treat an allergic inflammation of the esophagus, the Food and Drug Administration s… [+1516 chars]

Leave a Reply

Your email address will not be published. Required fields are marked *